Treating Class V Lesions | 合法醫療器材資訊網
![Treating Class V Lesions](https://i.imgur.com/6y29Lx7.jpg)
2017年7月27日—ClassVrestorationscanbechallengingtofillbecauseofthecontractionthatoccursduringcompositecuring.Typicallyduringthecontractionthe ...
![Treating Class V Lesions](https://i.imgur.com/6y29Lx7.jpg)
In a previous article, I went over the steps I take when working with direct composites in the posterior[1]. For this article I’d like to review the steps I use for placing direct composites in Class V lesions. Class V lesions, commonly referred to as cervical erosion, and in the literature as NCCLs (non-carious cervical lesions), can be extremely difficult to restore predictably.
Tay and Pashley described the bonding difficulties well in a review article citing the following challenges:
Mineral salts occlude the dentinal tubules which prevents resin tag formation Many parts of the lesion show a hyper-mineralized surface that resists self etching primers and phosphoric acid Significantly lower bond strengths than normal dentin due to the sclerotic nature of the dentin in the occlusal, gingival Deeper layers of the lesion ...(PDF) Alternative Technique for Class V Resin Composite ... | 合法醫療器材資訊網
(PDF) Direct | 合法醫療器材資訊網
Creating the “Perfect” Class V Composite | 合法醫療器材資訊網
The Closing Gap Technique. The perfect seal in Class 5 ... | 合法醫療器材資訊網
Treating Class V Lesions | 合法醫療器材資訊網
“Smart” Class V Preparation Design for Direct Composites ... | 合法醫療器材資訊網
![](https://i.imgur.com/6y29Lx7.jpg)
【3M菲特波克齒體填充後牙復形材料】許可證字號:衛部醫器輸字第027378號
器材品名:3M菲特波克齒體填充後牙復形材料許可證字號:衛部醫器輸字第027378號註銷狀態:註銷日期:註銷理由:有效日期:2025/05/...
![](https://i.imgur.com/6y29Lx7.jpg)
【"3M" 菲特流動性複合樹脂補牙材】許可證字號:衛署醫器輸字第010677號
器材品名:"3M"菲特流動性複合樹脂補牙材許可證字號:衛署醫器輸字第010677號註銷狀態:已註銷註銷日期:2012/11/19註銷理由:許...
![](https://i.imgur.com/6y29Lx7.jpg)
【“瑞可登”複合樹脂補牙材】許可證字號:衛部醫器製字第004482號
器材品名:“瑞可登”複合樹脂補牙材許可證字號:衛部醫器製字第004482號註銷狀態:已註銷註銷日期:2016/09/22註銷理由:自請註銷...
![](https://i.imgur.com/6y29Lx7.jpg)
【3M 前後牙通用複合樹脂補牙材】許可證字號:衛署醫器輸字第020662號
器材品名:3M前後牙通用複合樹脂補牙材許可證字號:衛署醫器輸字第020662號註銷狀態:註銷日期:註銷理由:有效日期:2025/03/12發...